Catalyst Wire Dossier Catalyst Wire Dossier

Anti-PD-1 antibody

Drug timelines are a Plus or Pro feature.

61 regulatory and trial events tracked for Anti-PD-1 antibody, covering 2016-09-13 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM [Phase 1]

See pricing